Friday, 20 October 2017

OPPI elects A. Vaidheesh as president

27 September 2017 | News

He takes over from Dr Shailesh Ayyangar, managing director, India & Head - South Asia, Sanofi who held this position since 2013.

The Organisation of Pharmaceutical Producers of India (OPPI), which represents research-based pharmaceutical companies in India, has unanimously elected A Vaidheesh, vice president, South Asia & managing director, GlaxoSmithKline Pharmaceuticals as president for the year 2017-18.

He takes over from Dr Shailesh Ayyangar, managing director, India & Head - South Asia, Sanofi who held this position since 2013. The four elected vice presidents are Sharad Tyagi, managing director, Boehringer Ingelheim; Sanjiv Navangul, managing director, Janssen India (Pharmaceutical Companies of Johnson & Johnson Ltd); S Sridhar, managing director, Pfizer Ltd and Anand Nambiar, managing director, Merck India Ltd.

The member companies of OPPI have played a very important and responsible role in collaborating with the Government and various stakeholder groups to ensure that high quality, innovative and essential medicines are available at affordable prices across India. Along with an inclusive ecosystem, in the coming years, healthcare financing will also play its role in improving access to healthcare. OPPI has clear priorities and along with the OPPI Secretariat led by Kanchana TK, Director General, OPPI, Vaidheesh plans on working towards serving more patients in India.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Is India becoming dependent on imports for key drug intermediates?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls